Silencing of glucose-regulated protein 78 (GRP78) enhances cell migration through the upregulation of vimentin in hepatocellular carcinoma cells

Annals of Surgical Oncology

Volumn 19, Issue SUPPL. 3, 2012, Pages

  Wei, Po Li ^a,b,c   Kuo, Li Jen ^a,b,c   Wang, Weu ^b,c   Lin, Feng Yen ^a,b   Liu, Hui Hsiung ^d   How, Tseng ^a   Ho, Yuan Soon ^a,d   Huang, Ming Te ^a,b,e   Wu, Chih Hsiung ^a,b,e   Chang, Yu Jia ^a,b,c,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUCOSE REGULATED PROTEIN 78; RNA; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; LIVER CELL CARCINOMA; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENETIC VECTORS; HEAT-SHOCK PROTEINS; HUMANS; LIVER NEOPLASMS; RNA INTERFERENCE; UP-REGULATION; VIMENTIN;

EID: 84865023281     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2055-y     Document Type: Article

References (46)

1. I Kim W Xu JC Reed 2008 Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities Nat Rev Drug Discov. 7 1013 1030 19043451 10.1038/nrd2755 1:CAS:528:DC%2BD1cXhsVenu7%2FM
2. DT Rutkowski RJ Kaufman 2004 A trip to the ER: coping with stress Trends Cell Biol. 14 20 28 14729177 10.1016/j.tcb.2003.11.001 1:CAS:528: DC%2BD2cXjtFegsw%3D%3D
3. AS Lee 2005 The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress Methods. 35 373 381 15804610 10.1016/j.ymeth.2004.10.010 1:CAS:528:DC%2BD2MXivVSntLg%3D
4. S Luo C Mao B Lee AS Lee 2006 GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development Mol Cell Biol. 26 5688 5697 16847323 10.1128/MCB.00779-06 1:CAS:528:DC%2BD28Xns1Cnsr0%3D
5. AS Lee 2007 GRP78 induction in cancer: therapeutic and prognostic implications Cancer Res. 67 3496 3499 17440054 10.1158/0008-5472.CAN-07-0325 1:CAS:528:DC%2BD2sXkt1KjtLo%3D
6. W Fu X Wu J Li Z Mo Z Yang W Huang, et al. 2010 Upregulation of GRP78 in renal cell carcinoma and its significance Urology. 75 603 607 19616278 10.1016/j.urology.2009.05.007
7. CC Chiu CY Lin LY Lee YJ Chen TF Kuo JT Chang, et al. 2008 Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention Mol Cancer Ther. 7 2788 2797 18790759 10.1158/1535-7163.MCT-08-0172 1:CAS:528:DC%2BD1cXhtFSms7bI
8. S Daneshmand ML Quek E Lin C Lee RJ Cote D Hawes, et al. 2007 Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival Hum Pathol. 38 1547 1552 17640713 10.1016/j.humpath.2007.03.014 1:CAS:528:DC%2BD2sXhtVOgu77E
9. HC Zheng H Takahashi XH Li T Hara S Masuda YF Guan, et al. 2008 Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas Hum Pathol. 39 1042 1049 18482745 10.1016/j.humpath.2007.11.009 1:CAS:528:DC%2BD1cXnsF2qu74%3D
10. E Lee P Nichols D Spicer S Groshen MC Yu AS Lee 2006 GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer Cancer Res. 66 7849 7853 16912156 10.1158/0008-5472.CAN-06-1660 1:CAS:528:DC%2BD28XotFWqsbw%3D
11. E Lee P Nichols S Groshen D Spicer AS Lee 2011 GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy Int J Cancer. 128 726 731 20473863 10.1002/ijc.25370 1:CAS:528:DC%2BC3cXhsVOktL%2FN
12. Y Fu AS Lee 2006 Glucose regulated proteins in cancer progression, drug resistance and immunotherapy Cancer Biol Ther. 5 741 744 16861902 10.4161/cbt.5.7.2970 1:CAS:528:DC%2BD28XhtVOju77I
13. XP Feng H Yi MY Li XH Li B Yi PF Zhang, et al. 2010 Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics Cancer Res. 70 3450 3462 20406978 10.1158/0008-5472.CAN-09-4099 1:CAS:528:DC%2BC3cXltlegu7s%3D
14. R Su Z Li H Li H Song C Bao J Wei, et al. 2010 Grp78 promotes the invasion of hepatocellular carcinoma BMC Cancer. 10 20 20082722 10.1186/1471-2407-10-20
15. J Zhang Y Jiang Z Jia Q Li W Gong L Wang, et al. 2006 Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer Clin Exp Metastasis. 23 401 410 17187227 10.1007/s10585-006-9051-9
16. TT Huang JY Chen CE Tseng YC Su HC Ho MS Lee, et al. 2010 Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan J Formos Med Assoc. 109 326 337 20497865 10.1016/S0929-6646(10)60060-5 1:CAS:528:DC%2BC3cXosF2mtbg%3D
17. JM Luk CT Lam AF Siu BY Lam IO Ng MY Hu, et al. 2006 Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values Proteomics. 6 1049 1057 16400691 10.1002/pmic.200500306 1:CAS:528: DC%2BD28XhvFWrsrY%3D
18. SO Lim SG Park JH Yoo YM Park HJ Kim KT Jang, et al. 2005 Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules World J Gastroenterol 11 2072 2079 15810071 1:CAS:528:DC%2BD2MXktlWrsb0%3D
19. JP Thiery H Acloque RY Huang MA Nieto 2009 Epithelial-mesenchymal transitions in development and disease Cell 139 871 890 19945376 10.1016/j.cell.2009.11.007 1:CAS:528:DC%2BC3cXksFWltA%3D%3D
20. H Peinado D Olmeda A Cano 2007 Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 7 415 428 17508028 10.1038/nrc2131 1:CAS:528:DC%2BD2sXls1Kjs70%3D
21. MA Huber N Kraut H Beug 2005 Molecular requirements for epithelial-mesenchymal transition during tumor progression Curr Opin Cell Biol. 17 548 558 16098727 10.1016/j.ceb.2005.08.001 1:CAS:528:DC%2BD2MXhtVWnsb7L
22. MI Kokkinos R Wafai MK Wong DF Newgreen EW Thompson M Waltham 2007 Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo Cells Tissues Organs. 185 191 203 17587825 10.1159/000101320 1:CAS:528:DC%2BD2sXmvFSnu70%3D
23. Y Kang J Massague 2004 Epithelial-mesenchymal transitions: twist in development and metastasis Cell. 118 277 279 15294153 10.1016/j.cell.2004.07.011 1:CAS:528:DC%2BD2cXmslKrs7w%3D
24. L Larue A Bellacosa 2005 Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways Oncogene. 24 7443 7454 16288291 10.1038/sj.onc.1209091 1:CAS:528:DC%2BD2MXht1Wis7vE
25. K Wu B Bonavida 2009 The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs Crit Rev Immunol. 29 241 254 19538137 10.1615/CritRevImmunol. v29.i3.40 1:CAS:528:DC%2BD1MXovVCntLw%3D
26. T Brabletz F Hlubek S Spaderna O Schmalhofer E Hiendlmeyer A Jung, et al. 2005 Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin Cells Tissues Organs. 179 56 65 15942193 10.1159/000084509 1:CAS:528: DC%2BD2MXkvVOnsro%3D
27. O Schmalhofer S Brabletz T Brabletz 2009 E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer Cancer Metastasis Rev. 28 151 166 19153669 10.1007/s10555-008-9179-y 1:CAS:528:DC%2BD1MXjsVWnsbc%3D
28. YJ Chang CC Chiu CH Wu J An CC Wu TZ Liu, et al. 2010 Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma Ann Surg Oncol. 17 1703 1709 20087778 10.1245/s10434-010-0912-8
29. JF Chiou CJ Tai MT Huang PL Wei YH Wang J An, et al. 2010 Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma Ann Surg Oncol. 17 603 612 19830497 10.1245/s10434-009-0718-8
30. D Dong B Ko P Baumeister S Swenson F Costa F Markland, et al. 2005 Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment Cancer Res. 65 5785 5791 15994954 10.1158/0008-5472.CAN-05-0754 1:CAS:528:DC%2BD2MXlslOqsbg%3D
31. SK Wang PH Liang RD Astronomo TL Hsu SL Hsieh DR Burton, et al. 2008 Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN Proc Natl Acad Sci U S A. 105 3690 3695 18310320 10.1073/pnas.0712326105 1:CAS:528:DC%2BD1cXjs1Oit7s%3D
32. S Sowinski C Jolly O Berninghausen MA Purbhoo A Chauveau K Köhler, et al. 2008 Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission Nat Cell Biol. 10 211 219 18193035 10.1038/ncb1682 1:CAS:528:DC%2BD1cXhs1Kiuro%3D
33. PL Wei LJ Kuo MT Huang WC Ting YS Ho W Wang, et al. 2011 Nicotine Enhances Colon Cancer Cell Migration by Induction of Fibronectin Ann Surg Oncol. 18 1782 1790 21210228 10.1245/s10434-010-1504-3
34. MT Huang PL Wei JJ Liu DZ Liu H Huey-Chun J An, et al. 2010 Knockdown of thrombomodulin enhances HCC cell migration through increase of ZEB1 and decrease of E-cadherin gene expression Ann Surg Oncol. 17 3379 3385 20625840 10.1245/s10434-010-1163-4
35. PL Wei YJ Chang YS Ho CH Lee YY Yang J An, et al. 2009 Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine receptor Ann Surg. 249 978 985 19474681 10.1097/SLA. 0b013e3181a6ce7e
36. L Zhuang RA Scolyer CS Lee SW McCarthy WA Cooper XD Zhang, et al. 2009 Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma Histopathology. 54 462 470 19309398 10.1111/j.1365-2559.2009.03242.x
37. A Sugioka T Tsuzuki T Kanai 1993 Postresection prognosis of patients with hepatocellular carcinoma Surgery. 113 612 618 8389492 1:STN:280: DyaK3s3otF2gtA%3D%3D
38. KJ Paquet P Koussouris MA Mercado JF Kalk D Müting W Rambach 1991 Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study Br J Surg. 78 459 462 1851652 10.1002/bjs.1800780423 1:STN:280:DyaK3M3jsFSiug%3D%3D
39. Primary liver cancer in Japan 1990 Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan Ann Surg. 211 277 287
40. JE Eriksson T Dechat B Grin B Helfand M Mendez HM Pallari, et al. 2009 Introducing intermediate filaments: from discovery to disease J Clin Invest. 119 1763 1771 19587451 10.1172/JCI38339 1:CAS:528:DC%2BD1MXosVCkurg%3D
41. B Eckes D Dogic E Colucci-Guyon N Wang A Maniotis D Ingber, et al. 1998 Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts J Cell Sci. 111 1897 1907 9625752 1:CAS:528:DyaK1cXkvVKmt7c%3D
42. D Tsuruta JC Jones 2003 The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial cells subjected to shear stress J Cell Sci. 116 4977 4984 14625391 10.1242/jcs.00823 1:CAS:528:DC%2BD2cXhsFOmug%3D%3D
43. J Ivaska 2011 Vimentin. Central hub in EMT induction? Small Gtpases 2 51 53 21686283 10.4161/sgtp.2.1.15114
44. Suzuki H, Murata K, Gotoh T, Kusano M, Okano H, Oyamada T, et al. Phenotype-dependent production of des-gamma-carboxy prothrombin in hepatocellular carcinoma. J Gastroenterol. 2011 [Epub ahead of print].
45. Y Kitamura A Shirahata K Sakuraba T Goto H Mizukami M Saito, et al. 2011 Aberrant methylation of the Vimentin gene in hepatocellular carcinoma Anticancer Res. 31 1289 1291 21508377
46. G Lahat QS Zhu KL Huang S Wang S Bolshakov J Liu, et al. 2010 Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies PLoS One. 5 e10105 20419128 10.1371/journal.pone.0010105